إعلان
إعلان

MGX

MGX logo

Metagenomi, Inc. Common Stock

1.79
USD
برعاية
+0.02
+1.41%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
exchange

بعد الإغلاق

1.77

-0.02
-1.11%

تقارير أرباح MGX

النسبة الإيجابية المفاجئة

MGX تفوق 6 من 8 آخر التقديرات.

75%

التقرير التالي

بيانات التقرير القادم
١١ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$6.81M
/
-$0.61
التغير الضمني من Q3 25 (Revenue/ EPS)
-21.33%
/
+10.91%
التغير الضمني من Q4 24 (Revenue/ EPS)
-29.15%
/
-3.17%

Metagenomi, Inc. Common Stock earnings per share and revenue

On ١١ نوفمبر ٢٠٢٥, MGX reported earnings of -0.55 USD per share (EPS) for Q3 25, beating the estimate of -0.58 USD, resulting in a 6.75% surprise. Revenue reached 8.66 مليون, compared to an expected 7.47 مليون, with a 15.85% difference. The market reacted with a -15.45% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 6 المحللين forecast an EPS of -0.61 USD, with revenue projected to reach 6.81 مليون USD, implying an زيادة of 10.91% EPS, and نقصان of -21.33% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, Metagenomi, Inc. Common Stock reported EPS of -$0.55, beating estimates by 6.75%, and revenue of $8.66M, 15.85% above expectations.
The stock price moved down -15.45%, changed from $2.20 before the earnings release to $1.86 the day after.
The next earning report is scheduled for ١١ مارس ٢٠٢٦.
Based on 6 المحللين, Metagenomi, Inc. Common Stock is expected to report EPS of -$0.61 and revenue of $6.81M for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان